Obesity Medicine Association

Also known as: OMA · American Society of Bariatric Physicians (former name) · ASBP (former acronym)

Definition

The Obesity Medicine Association (OMA) is the largest professional organization of clinicians in the United States and internationally dedicated to the comprehensive, evidence-based medical treatment of obesity. Its membership includes physicians, nurse practitioners, physician assistants, registered dietitians, and other healthcare professionals who specialize in treating obesity as a chronic, progressive, and relapsing metabolic disease (OMA).

The association serves as a primary educational resource, providing accredited continuing medical education (CME), clinical tools, and practice management resources. A core contribution of the OMA is the development and dissemination of clinical guidelines, such as the Obesity Algorithm, which outlines evidence-based protocols for obesity management across four main pillars: nutrition, physical activity, behavior modification, and pharmacotherapy. The OMA also plays a key role in preparing clinicians for the American Board of Obesity Medicine (ABOM) certification exam, helping establish professional standards in obesity care (ABOM).

Identities

Source Type	Identity
Wikipedia	N/A
Wikidata	N/A
DBpedia	N/A
ProductOntology	N/A
Wiktionary	N/A
Library of Congress Subject Headings (LCSH)	N/A
MeSH	N/A
NCBI Taxonomy	N/A
AGROVOC	N/A
Google Scholar	Obesity Medicine Association OMA Obesity Algorithm
ConceptNet	N/A
OpenCyc	N/A

Also Known As

OMA
American Society of Bariatric Physicians (former name)
ASBP (former acronym)

Geography and Climate

The Obesity Medicine Association is headquartered in Denver, Colorado, United States. Denver’s geographical location as a major transportation and commercial hub in the Rocky Mountain region supports the association’s administrative operations and its ability to host large-scale medical education events. While the administrative core is in Colorado, the OMA’s clinical and educational reach is global, with members and certified clinicians practicing in multiple countries, including the Philippines.

The geographic distribution of OMA members is highly relevant to how obesity care is adapted to different climates and cultural settings. Clinicians in varying climates must adapt their lifestyle recommendations to regional environmental conditions. For instance, in hot, humid tropical regions like the Philippines, clinical advice regarding physical activity must account for heat-related risks, necessitating indoor activity options or exercise during cooler times of the day. The local geography also shapes dietary recommendations, with clinicians guiding patients to choose locally available, nutrient-dense whole foods that align with regional agricultural availability.

Demographics

The membership of the Obesity Medicine Association represents a diverse range of medical specialties and professional backgrounds. Members include primary care physicians, endocrinologists, cardiologists, pediatricians, nurse practitioners, physician assistants, registered dietitians, and clinical psychologists. This multidisciplinary composition reflects the complex nature of obesity, which requires a coordinated, multi-faceted clinical approach.

The patient population served by OMA members spans all demographic groups, including pediatric, adult, and geriatric patients affected by obesity or overweight. Clinical data indicate that obesity affects populations differently based on socioeconomic status, race, and ethnicity. OMA clinicians receive training to address these disparities, providing culturally sensitive care that accounts for genetic variations, cultural dietary patterns, and local socioeconomic barriers to healthy lifestyles.

Economy and Industry

The Obesity Medicine Association plays a key role in the economics of the obesity healthcare sector. The practice of obesity medicine is closely integrated with the pharmaceutical, medical device, and nutritional industries. OMA provides independent, evidence-based evaluations of new anti-obesity medications, such as GLP-1 receptor agonists and dual GIP/GLP-1 agonists, helping clinicians understand their role in clinical practice.

In the Philippines, the growth of obesity medicine as a clinical specialty has significant economic implications. The introduction of premium anti-obesity medications has created a fast-growing market within the private healthcare sector. However, the high out-of-pocket cost of these treatments creates access barriers for lower-income patients. OMA’s educational resources assist local clinicians in designing cost-effective treatment plans that combine pharmacotherapy with low-cost lifestyle interventions, helping to optimize clinical outcomes within the financial constraints of patients.

Transportation and Infrastructure

The operations of the Obesity Medicine Association rely on modern digital and physical infrastructure. OMA hosts major annual educational conferences, such as the Obesity Medicine Summit, which require international transport logistics, convention center facilities, and digital broadcast infrastructure to support virtual attendance for global members.

For clinical education, the OMA maintains a digital learning platform that provides webinars, podcasts, and online master courses, allowing healthcare professionals in countries like the Philippines to access advanced clinical training without the need for international travel. The association also publishes clinical tools, including the Obesity Algorithm, which are distributed digitally to clinicians worldwide to support evidence-based decision-making at the point of care.

Culture and Tourism

The Obesity Medicine Association has contributed to a major cultural shift in how obesity is understood by the medical community and the public. Historically, obesity was widely viewed in popular culture and media as a cosmetic issue or a failure of personal discipline. Through its educational campaigns and clinical guidelines, the OMA has advocated for the medical recognition of obesity as a primary, chronic disease, helping to reduce weight bias and stigma in clinical settings.

In the medical tourism sector, the demand for structured weight-management programs has influenced wellness and medical travel. High-quality wellness resorts and clinical facilities, including specialized health centers in the Philippines, integrate OMA-aligned protocols into their services. These centers offer comprehensive programs that combine medical metabolic supervision with physical therapy, nutritional counseling, and stress-management techniques to support international patients seeking metabolic health improvements.

Government and Administration

The Obesity Medicine Association engages in clinical advocacy to shape public health policy and government regulation. In the United States, the OMA works with organizations like the Obesity Care Advocacy Network (OCAN) to advocate for legislative changes, such as the Treat and Reduce Obesity Act (TROA), which aims to expand Medicare coverage for medical weight management and intensive behavioral therapy.

In the Philippines, the principles of evidence-based obesity medicine are promoted by local medical societies, such as the Philippine Association for the Study of Overweight and Obesity (PASOO), which collaborates with the Department of Health (DOH) to update national health guidelines. OMA’s educational resources provide a clinical benchmark that helps local societies advocate for the integration of comprehensive obesity care into national health strategies, aiming to reduce the long-term public health burden of metabolic diseases.

Education and Healthcare

Education is the primary mission of the Obesity Medicine Association. OMA is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide AMA PRA Category 1 Credits for its educational activities. The association offers comprehensive review courses designed to prepare physicians for the American Board of Obesity Medicine (ABOM) certification exam, which has become a recognized credential in the medical field.

In healthcare delivery, the OMA’s guidelines emphasize a comprehensive, four-pillar treatment model. Clinicians are trained to evaluate patients’ nutritional patterns, physical activity levels, behavioral factors (such as stress and sleep quality), and metabolic profiles. This structured approach helps healthcare systems deliver personalized, evidence-based care that addresses the root causes of weight gain and supports long-term metabolic health.

Examples and Analogies

The Four-Pillar Foundation: Imagine building a house on a single pillar; it would be unstable and vulnerable to collapse. Similarly, treating obesity through diet alone is often insufficient. The OMA’s clinical model is like a house built on four solid pillars—nutrition, physical activity, behavior, and medication—ensuring a stable, long-term foundation for health.
The Specialized Blueprint: In general medicine, obesity is often treated as a secondary symptom of other diseases. The OMA’s guidelines act like a specialized architectural blueprint, treating obesity as the primary disease and providing clinicians with a detailed plan to address the underlying metabolic pathways.
OMA vs. Surgical Societies: While bariatric surgical societies focus primarily on surgical interventions like gastric bypass, the Obesity Medicine Association focuses on non-surgical, medical management strategies, including pharmacotherapy, nutritional therapy, and behavioral counseling.

Usage Scenarios

1. Preparing for Board Certification

A family medicine physician in the Philippines utilizes the OMA’s online academy and review courses to study for the American Board of Obesity Medicine (ABOM) certification exam, aiming to establish a specialized metabolic health clinic.

2. Clinical Guideline Implementation

An endocrinologist integrates the OMA’s Obesity Algorithm into their clinical practice, using the structured four-pillar approach to design a personalized treatment plan for a patient with severe metabolic syndrome.

3. Patient Advocacy and Education

A nurse practitioner utilizes OMA’s patient education handouts and clinical tools to counsel a patient on the biological mechanisms of weight regain, helping the patient understand that obesity is a chronic disease requiring long-term care.

Strategies

Utilize the Obesity Algorithm: Access and apply the OMA’s Obesity Algorithm as a clinical guide to evaluate and treat the pathophysiological, environmental, and behavioral drivers of obesity.
Participate in Continuing Education: Attend OMA conferences and webinars to stay updated on the latest clinical trial data, pharmacological advancements, and practice-management strategies in obesity medicine.
Incorporate Multidisciplinary Care: Build a network of registered dietitians, physical therapists, and behavioral health specialists to support the implementation of the four-pillar treatment model in clinical practice.

Security and Safety Measures

Ensuring Patient Safety in Pharmacotherapy: Prior to prescribing anti-obesity medications, perform a comprehensive medical evaluation, including a review of cardiovascular history and contraindications, to ensure patient safety.
Addressing Weight Bias in Practice: Train clinical staff to use first-person language (e.g., “patient with obesity” rather than “obese patient”) and maintain a supportive, non-judgmental environment to prevent patient drop-out.
Safe Exercise Prescription: Ensure that physical activity recommendations are tailored to the patient’s musculoskeletal health and cardiovascular fitness, particularly for patients with severe obesity or pre-existing heart disease.

Historical Context

The origins of the Obesity Medicine Association date back to 1950 with the founding of the American Society of Bariatric Physicians (ASBP). During the mid-20th century, bariatric medicine focused primarily on early dietary interventions and early-generation medications.

Over the subsequent decades, the organization evolved to reflect advancements in the scientific understanding of energy regulation and adipose tissue biology. In 2015, the society changed its name to the Obesity Medicine Association to align with the modern clinical recognition of obesity as a primary disease. In recent years, the rapid development of incretin-based therapies, such as GLP-1 receptor agonists evaluated in the STEP and SURPASS trials, has expanded the pharmacological options available to OMA clinicians, establishing obesity medicine as a major clinical specialty.

Challenges and Controversies

Insurance and Coverage Limitations

A primary challenge faced by OMA members is the lack of insurance coverage for comprehensive obesity care. Many government and private health plans continue to classify weight-management services and medications as cosmetic or elective, limiting access to treatment for patients in lower-income demographics.

Industry Relationships and Independence

The rapid growth of the obesity pharmacotherapy market has led to close relationships between professional medical societies and pharmaceutical companies. Critics emphasize the importance of maintaining strict clinical independence and transparency in educational programming to ensure that guidelines are based on objective science rather than commercial interests.